AtriCure, Inc. (ATRC)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
74.54-2.84 (-3.67%)
At close: 4:00PM EDT
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
| Previous Close | 77.38 |
| Open | 76.40 |
| Bid | 53.19 x 1100 |
| Ask | 90.00 x 1300 |
| Day's Range | 74.21 - 76.94 |
| 52 Week Range | 34.04 - 80.44 |
| Volume | 498,955 |
| Avg. Volume | 370,958 |
| Market Cap | 3.401B |
| Beta (5Y Monthly) | 1.04 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.12 |
| Earnings Date | Jul 26, 2021 - Jul 30, 2021 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 88.00 |
- Business Wire
AtriCure Names Two New Members to the Board of Directors
MASON, Ohio, Jun 15, 2021--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced that Deborah H. Telman and Maggie Yuen have been elected to its Board of Directors.
- Simply Wall St.
Shareholders Will Most Likely Find AtriCure, Inc.'s (NASDAQ:ATRC) CEO Compensation Acceptable
AtriCure, Inc. ( NASDAQ:ATRC ) has exhibited strong share price growth in the past few years. However, its earnings...
- Zacks
AtriCure (ATRC) Soars 8.8%: Is Further Upside Left in the Stock?
AtriCure (ATRC) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
© 2021 Verizon Media. All rights reserved.
